Association Between High Sensitivity Cardiac Troponin and All-Cause and Cardiovascular Mortality in Adults at Risk of
Enfa Zhao1, Hang Xie2, Yuan Gao1
1Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China.
Insights
Elevated high-sensitivity cardiac troponin (hs-cTn) levels indicate myocardial injury, significantly increasing mortality risk in non-alcoholic fatty liver disease (NAFLD) patients. This finding suggests hs-cTn can help identify high-risk NAFLD individuals for targeted interventions.
Area of Science:
- Cardiology
- Hepatology
- Public Health
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a growing concern, with cardiovascular disease (CVD) being its primary cause of mortality.
- Identifying individuals at risk for adverse cardiovascular events within the NAFLD population is crucial for effective management.
Purpose of the Study:
- To investigate the association between elevated high-sensitivity cardiac troponin (hs-cTn) levels and mortality in US adults at risk for NAFLD.
- To determine if hs-cTn can serve as a prognostic marker for all-cause and CVD mortality in this population.
Main Methods:
- Analysis of data from 2581 adults at risk for NAFLD from the 1999-2004 National Health and Nutrition Examination Survey.
- Measurement of hs-cTn levels using various assays and linkage with the National Death Index for mortality outcomes until December 2019.
- Multivariable Cox proportional hazards models were employed to assess the association between myocardial injury (elevated hs-cTn) and mortality.
Main Results:
- Myocardial injury was identified in 7.01% of participants.
- Over a median follow-up of 16.7 years, myocardial injury was associated with significantly increased risks of all-cause mortality (aHR 1.785) and CVD mortality (aHR 2.155).
- The Siemens hs-cTn I assay showed the strongest association with all-cause mortality.
Conclusions:
- Elevated hs-cTn levels, indicative of myocardial injury, are independently linked to higher all-cause and cardiovascular mortality in US adults at risk for NAFLD.
- These findings underscore the potential utility of hs-cTn testing for risk stratification and guiding interventions in NAFLD patients, even those without pre-existing CVD.
- Routine hs-cTn assessment could improve prognostic accuracy and inform targeted therapeutic strategies in the NAFLD population.
Objective:
Cardiovascular disease (CVD) is the leading cause of death among patients with non-alcoholic fatty liver disease (NAFLD). This study investigates the association between high-sensitivity cardiac troponin (hs-cTn) levels and mortality in adults at risk of NAFLD in a representative U.S. population sample.
Methods:
Among participants aged 18 years and older in the 1999-2004 National Health and Nutrition Examination Survey, we measured high-sensitivity troponin T using a single assay (Roche) and high-sensitivity troponin I using three assays (Abbott, Siemens, and Ortho). Myocardial injury was identified by elevated levels of hs-cTn. Mortality outcomes were determined through linkage with the National Death Index database, with follow-up until December 31, 2019. A multivariable Cox proportional hazards model was used to evaluate the associations between myocardial injury and mortality in the NAFLD population. Sensitivity analyses were conducted to assess the robustness of the main findings.
Results:
A total of 2581 at risk of NAFLD were included in this observational study, with myocardial injury identified in 7.01%. Over a median follow-up of 16.7 years, 937 all-cause deaths occurred, including 319 cardiovascular disease-related deaths. NAFLD individuals with myocardial injury had worse survival rates at 5, 10, and 15 years compared to those without myocardial injury. After adjusting for baseline characteristics, myocardial injury was associated with an increased risk of all-cause mortality (adjusted Hazard Ratio [aHR] 1.785, 95% CI 1.494-2.134, P < 0.001) and cardiovascular mortality (aHR 2.155, 95% CI 1.606-2.893, P < 0.001).
Conclusion:
This large, nationally representative study demonstrates that myocardial injury, defined by elevated hs-cTn levels, is independently associated with increased all-cause and cardiovascular mortality risks in the adult population at risk of NAFLD in the United States. This association persisted after adjusting for various factors and in patients without pre-existing cardiovascular disease. The Siemens hs-cTn I assay demonstrated the strongest association with all-cause mortality. These findings highlight the potential of hs-cTn as a valuable prognostic marker in NAFLD patients, even in those without clinically apparent cardiovascular disease. Routine hs-cTn assessment may aid in risk stratification and guide targeted interventions to reduce mortality risk in this population.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...